Physician profile
Sonja Franklin
NPI 1407947542
$7,141.28
in general payments reported to CMS, 2019-2025
24 companies · $1,916 in 2025
The $1,916 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,098 · 2020: $315 · 2021: $660 · 2022: $1,109 · 2023: $847 · 2024: $1,197 · 2025: $1,916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,959.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,503.47 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Ortho-K Contact Lens |
| Alcon Vision LLC | $834.39 | 2019-2025 | Precision7, Total30, Tryptyr |
| Bausch & Lomb Americas INC. | $736.75 | 2023-2025 | Miebo, Infuse, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $695.05 | 2019-2021 | |
| Glaukos Corporation | $609.65 | 2019-2025 | Idosetr |
| Sun Pharmaceutical Industries INC. | $436.19 | 2022-2025 | Cequa |
| Biotissue Holdings INC. | $284.88 | 2022-2025 | |
| Johnson & Johnson Vision Care, INC. | $253.99 | 2019-2025 | Acuvue |
| Dompe US, INC. | $240.65 | 2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $229.85 | 2024 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $202.06 | 2019-2022 | |
| Sight Sciences, INC. | $144.95 | 2022 | |
| Kala Pharmaceuticals, INC. | $144.19 | 2021 | |
| Allergan, INC. | $139.52 | 2019 | |
| Rxsight INC | $123.37 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Injector Handpiece |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $122.08 | 2020 | |
| Abbvie INC. | $121.24 | 2025 | |
| Horizon Therapeutics Plc | $108.68 | 2022 | |
| Carl Zeiss Meditec, INC. | $77.60 | 2019-2020 | |
| Abb Con-Cise Optical Group LLC | $36.75 | 2019-2020 | |
| Carl Zeiss Meditec Ag | $34.40 | 2020 | |
| Visioneering Technologies, INC. | $30.29 | 2025 | |
| Optos, INC. | $18.78 | 2021 | |
| Amgen INC. | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonja Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.